Drug intelligence / Profile preview

Xinhuankangkeli

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Xinhuankangkeli is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of bradyarrhythmias (slow heart rhythms). It is administered as a granule preparation. The exact herbal composition and mechanism of action are not specified in the available clinical trial data, but as with many TCM products, it likely contains a combination of plant-derived ingredients intended to regulate cardiac rhythm and improve cardiovascular function. Its use has been studied in clinical settings for its effects on heart rate disorders[1].

Brand names: Xinhuankangkeli
Other names: Xin Huan Kang Ke Li新欢康颗粒

Beyond the preview

Go deeper on Xinhuankangkeli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinhuankangkeli.

Explore the full profile